Navigation Links
Clues to the Mystery of Lou Gehrig's Disease

Researchers have recently reported clues to unraveling the mystery of the disease best known for striking down New York Yankees first baseman Lou Gehrig nearly 70 years ago//.

According to Virginia Lee, Ph.D., of the University of Pennsylvania a team of researchers has identified the misfolded protein that causes both Lou Gehrig's disease or amyotrophic lateral sclerosis (ALS), as well as a less well-known disease, frontotemporal lobar degeneration.

The findings of the study, published in the Oct. 6 issue of Science identify it as TAR DNA-binding protein 43 (TDP-43), that has several functions and is found in the nucleus of many cell types.

Misfolded proteins are a common occurrence in neurodegenerative diseases. They are tagged for recycling by the protein ubiquitin, but instead of being broken down they are dumped in the neurons.

However Dr Lee said that the specific ubiquitinated protein involved in ALS and frontotemporal lobar degeneration had not been earlier identified. She and her colleagues noted that the finding "resolves a long-standing enigma."

Clinical features such as dementia and motor complications are common to both ALS and frontotemporal lobar degeneration patients which made researches consider the likelihood of the two diseases being related in some way.

Tests using tissue samples showed that the motor neurons of ALS patients and the frontal and temporal neurons of frontotemporal lobar degeneration patients contain large amounts of ubiquitinated TDP-43 in their cytoplasm.

The researchers therefore concluded that this finding implied that ALS, frontotemporal lobar degeneration, and possibly other neurodegenerative diseases are part of "a spectrum of disorders that share similar pathological mechanisms, culminating in the progressive degeneration of different selectively vulnerable neurons."

Dr Lee said, "It's very exciting that we finally made the connection between dem entia and motor neuron disease. Clinically there's overlap in these two disorders, so it was very tantalizing to see if there was anything to link them biochemically."

The researchers developed monoclonal antibodies to TDP-43, and tested them in 72 post-mortem tissue samples patients with either ALS or frontotemporal lobar degeneration and found that all 72 cases contained misfolded TDP-43. Dr Lee said, "Since many cases were studied, the data became very compelling."

According to study co-author John Trojanowksi, M.D., Ph.D., director of Penn's Institute on Aging although ALS is well-known because of its link with Gehrig, frontotemporal lobar degeneration is less well-known while this may be because of its rarity in spite of it being the second most common cause -- after Alzheimer's disease -- of dementia in people under the age of 65.

Dr. Trojanowksi said, "Another reason for (its) relative obscurity is also undoubtedly the shame family members experience with the strange and, at times, bizarre behavior of patients, including disturbing obsessions, larceny, or even sexual deviancy, that may bring the patient to the attention of the legal system rather than to the healthcare system."

Dr Lee pointed out that usefulness of the finding depends on whether future research shows that TDP-43 is a useful target for new therapies and diagnostic tools.
NLA
'"/>




Related medicine news :

1. Innovative yeast genome may handle Cancer Clues
2. Researchers Discover New Clues To Identify Tooth Decay
3. Leeches Provide Clues Regarding The Prevention Of Heart Disease
4. Excavations Reveal Clues Of Early Warfare
5. Sleeping Computers Yield Clues About Genetic Disorders
6. Clues To Identify Psychological Seizures
7. A Human Brain Gene Could Hold Clues On The Evolution Of Brain Capacity
8. Clues Found On How Deadly Bacterium Gains Foothold
9. Clues to Allay Aging
10. Regrowth of Zebrafishs Tail Fin may Offer Clues for Treating Human Injuries
11. Renegade RNA: Clues to Cancer and Normal Growth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... working together to expand dental health services to the developmentally disabled in the ... Care Dental’s operations to a new facility at 71-949 Highway 111, Suite 100-B, ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... tracking solution, The Guard, to associations of medical professionals throughout the country. The ... including security risk assessments, policies and procedures, employee training, regulatory updates, and compliance ...
(Date:2/10/2016)... ... ... Dr. Jessica Barron, of Barron Family Dental in Thornton, Colorado , is ... the North Metro Denver area. The new dental practice focuses on comfort where patients ... the most relaxing environment. , While some dental visits can create anxiety for patients, ...
(Date:2/10/2016)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral ... December 31, 2015 on Monday, February 29, 2016 after the market closes. , The ... release at 4:30 PM ET. Investors interested in participating by phone are invited to ...
(Date:2/10/2016)... MN (PRWEB) , ... February 10, 2016 , ... ... that it will attend the Ohio Safety Congress and Expo event March 9-11, ... at the Greater Columbus Convention Center. , As the longest running and ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016 CERS ), Medivation, Inc. (NASDAQ: ... and Celldex Therapeutics, Inc. (NASDAQ: CLDX ). --> ... Pharmaceuticals, Inc. (NASDAQ: ADMS ) and Celldex Therapeutics, Inc. ... Drug Designations become vitally important in the development of targeted ... and biologics which are defined as those intended for the ...
(Date:2/10/2016)... 2016 ALSP, Inc. announced that it has appointed ... Medical Affairs in preparation for its move into clinical trials ... CEO, stated, "We are pleased to welcome Dallas Hack ... with an individual of such practical knowledge and far-reaching experience ... deeply on his broad experience and success as a clinician ...
(Date:2/10/2016)... 9, 2016 On Tuesday, February ... met with its Arthritis Advisory Committee to ... Johnson & Johnson,s Remicade and most likely ... the U.S. The Biologics Prescribers Collaborative (BPC) ... Alliance for Patient Access, American Association of ...
Breaking Medicine Technology: